(7E)-Cyclohexadec-7-en-1-one
Common Name: |
(7E)-Cyclohexadec-7-en-1-one |
IUPAC Name: |
(7E)-cyclohexadec-7-en-1-one |
Molecular Formula: |
C8H14O2 |
SMILES: |
C1CCCCC(=O)CCCCCC=CCCC1 |
Inchi: |
1S/C16H28O/c17-16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-16/h2,4H,1,3,5-15H2/b4-2+ |
Inchi Key: |
CMFUATSDNFKABN-DUXPYHPUSA-N |
Cas No: |
2550-59-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
142.20 |
Mass (g/mol) |
236.214 |
Molar Refractivity |
41.38 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
351.00 to 352.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
5.197 |
iLOGP |
2.22 |
XLOGP3 |
1.38 |
WLOGP |
1.56 |
MLOGP |
1.04 |
ESOL Log S |
-1.20 |
ESOL Solubility (mg/ml) |
9.08 |
ESOL Solubility (mol/l) |
0.064 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.54 |
Ali Solubility (mg/ml) |
4.14 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.64 |
Silicos-IT Solubility (mg/ml) |
3.26 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.69 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.092 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |